ArticleJournal of thoracic disease2025

Four-year outcomes with perioperative toripalimab plus chemotherapy in resectable stage III non-small cell lung cancer (NeoTAP01 study).

Yuheng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.